Lung Cancer Tests: Screening, Diagnosis, and What to Expect

Understand the full range of lung cancer tests, screening guidelines, diagnostic tools, and what each step involves from early detection to tissue analysis.

By Medha deb

Created on Sep 25, 2025

Understand the full range of lung cancer tests, screening guidelines, diagnostic tools, and what each step involves from early detection to tissue analysis.

Lung cancer is among the most common and deadly cancers worldwide, largely because it’s often detected late. Understanding which tests are used to find or diagnose lung cancer, who should be screened, and what these procedures involve can make detection and treatment more manageable—and can potentially save lives. This guide details essential information on lung cancer tests, screening recommendations, what to expect before and after testing, and answers to commonly asked questions about the process.

Why Early Detection of Lung Cancer Matters

Early detection significantly increases the chances of successful lung cancer treatment. Unfortunately, most cases are identified after symptoms appear and the disease has advanced. The American Lung Association reports that just 26.6% of lung cancers are found in the early stages. Early screening can reduce mortality among high-risk individuals by 14–20%. Screening detects cancer before symptoms arise—when it is most treatable, making prompt action critical for improving outcomes.

Early detection often leads to more treatment options and better survival rates.

Lung cancers found late are harder to treat and associated with a lower survival rate.

Many symptoms (like persistent cough, chest pain, or weight loss) develop only after the disease has progressed.

Who Should Get Screened for Lung Cancer?

Screening is not recommended for everyone. It is typically advised for people at highest risk—primarily long-term smokers and those with significant risk factors. Major guidelines recommend screening for those who:

Are aged 50 to 80 years old

Have at least a 20 pack-year smoking history (equivalent to a pack a day for 20 years)

Currently smoke or have quit within the past 15 years

Certain environmental exposures (asbestos, radon), family history of lung cancer, or significant occupational hazards also increase risk and may justify earlier or additional screening in select cases.

Common Symptoms Leading to Testing

Lung cancer often does not cause symptoms in early stages. Symptoms that might lead to suspicion or testing include:

Persistent cough that does not resolve or worsens

Coughing up blood or rust-colored sputum

Chest pain, especially during deep breathing or coughing

Shortness of breath or wheezing

Unexplained weight loss or loss of appetite

Voice hoarseness or new bone pain

Many of these symptoms overlap with less serious conditions but warrant medical evaluation, especially in at-risk individuals.

Lung Cancer Screening: How Is It Done?

The only recommended method for lung cancer screening is a low-dose computed tomography (LDCT) scan. This painless imaging test is designed to detect lung cancer in people who have no symptoms but are considered high-risk.

Low-Dose CT (LDCT) Scan: What to Expect

Preparation: Remove metal items such as jewelry; you may need to change into a gown.

During the scan: You lie on a table that slides in and out of the doughnut-shaped scanner. The scan is quick, often taking less than a minute. You may be asked to hold your breath briefly to improve image quality.

Painless: The scan is entirely noninvasive and does not cause discomfort.

After the scan: You can return to any normal activities, and your doctor will review and discuss the results with you soon after.

Benefits and Risks of LDCT Screening

Benefits:

Can detect up to 80% of lung cancers at an earlier stage—when they’re easiest to treat

Reduced lung cancer mortality in high-risk groups

Risks:

Exposure to a small amount of radiation with each scan

Potential for false-positive results (finding something that isn’t cancer)

Risk of overdiagnosis, leading to unnecessary anxiety or additional tests for harmless abnormalities

Most health insurance plans cover the cost of LDCT screening for those meeting established risk criteria.

Imaging and Diagnostic Tests for Suspected Lung Cancer

Beyond screening, if doctors suspect lung cancer due to your symptoms or a suspicious nodule found incidentally, they will order diagnostic tests to confirm the presence and type of cancer.

Major Imaging Tests Used

nnn

Test	Purpose	Key Features
Chest X-ray	Initial look for lung masses or abnormalities	Quick, widely available, low radiation
CT Scan	Detailed images for size, shape, and location of tumors	High-resolution, cross-sectional, more sensitive than X-ray
MRI	Checks spread, especially to the brain or spinal cord	Excellent soft tissue contrast, no radiation
PET Scan	Finds active cancer cells and spread (metastasis)	Uses radioactive tracer, helps guide biopsy/treatment
Bone Scan	Detects if cancer has spread to bones	Radioactive tracer, specific for bone involvement

Imaging tests help locate tumors, evaluate their size, and determine if cancer has spread beyond the lungs.

Diagnostic Procedures and Tissue Sampling

If imaging suggests cancer, your doctor will use one or more of the following procedures to obtain tissue samples:

Sputum Cytology: Examines coughed-up mucus for cancer cells.

Bronchoscopy: Uses a thin, flexible tube inserted into the airways to visually inspect the lungs and take biopsy samples.

Needle Biopsy: Uses a thin needle, often guided by CT or ultrasound images, to withdraw cells from a suspected tumor.

Mediastinoscopy: A minor surgical procedure to sample lymph nodes via a small incision at the base of the neck.

Thoracentesis: Removes fluid from around the lungs (pleural space) for analysis, especially if cancer is suspected there.

These biopsies help confirm the diagnosis, identify the specific type of lung cancer (such as non-small cell or small cell), and guide the treatment strategy.

Blood Tests and Emerging Technologies

Blood tests are not currently approved or widely used for lung cancer screening. However, researchers are exploring several types of blood-based tests—sometimes called “liquid biopsies”—that look for DNA, proteins, or circulating markers released by cancer cells. If successful, these tests could allow for even less invasive and earlier detection of lung cancer in the future. For now, LDCT remains the gold standard for screening, while tissue biopsy is required for a definitive diagnosis.

What Happens After Testing?

Your doctor will discuss the results of your imaging or diagnostic tests. If cancer is found, additional tests may be performed to:

Determine the type of lung cancer (e.g., non-small cell vs. small cell)

Stage the cancer by checking for spread to lymph nodes or other organs

Decide on the best treatment options based on your health, cancer type, and stage

Even if your test is negative, your doctor may recommend follow-up tests or surveillance if you have ongoing risk factors or concerning abnormalities on imaging. Understanding your next steps and actively communicating with your care team is essential.

Frequently Asked Questions (FAQs) About Lung Cancer Testing

What are the first signs that may prompt lung cancer testing?

Early-stage lung cancer often causes no symptoms. Common warning signs include persistent or worsening cough, coughing up blood, unexplained weight loss, chest pain, or shortness of breath. People with these symptoms—especially those with risk factors such as a history of heavy smoking—should see their healthcare provider promptly.

Who qualifies for lung cancer screening?

Current guidelines recommend annual LDCT screening for adults aged 50–80 years with a 20-pack-year smoking history who currently smoke or have quit within the past 15 years. Other high-risk factors can be considered in consultation with your doctor.

Is a blood test currently available for lung cancer screening?

No. While research into blood-based lung cancer screening is promising, no blood tests are approved for routine lung cancer screening or diagnosis outside clinical trials.

Are lung cancer screening tests safe?

Low-dose CT scans use a much lower dose of radiation than standard CT scans, and the screening protocol is designed to minimize risk. Other risks include false positives or incidental findings, which may require additional imaging or follow-up procedures.

How is lung cancer diagnosis confirmed?

Definitive diagnosis always relies on pathology—examining cancerous cells or tissue from a biopsy sample. Imaging tests can suggest cancer, but only laboratory analysis of sampled tissue confirms the diagnosis and cancer type.

Tips for Navigating Lung Cancer Testing

Talk openly with your healthcare provider about your risk factors, history, and eligibility for screening.

Report any of the warning signs or symptoms of lung cancer, even if you believe them to be related to another condition.

Ask questions about what to expect before, during, and after each test or screening.

Understand your insurance coverage for recommended screening and diagnostic procedures.

Seek support: Diagnosis and testing can be stressful. Don’t hesitate to involve friends, family, or support organizations in your care process.

Summary Table: Lung Cancer Testing and Diagnosis Methods

nnn

Test or Procedure	What It Does	When Used
LDCT Screening	Detects early lung cancer in asymptomatic, high-risk people	Annual screening for eligible adults
Chest X-ray	Detects masses or abnormal lung shadows	Initial evaluation or as part of routine care
CT Scan	Detailed imaging to pinpoint tumors	Diagnostic workup post-symptoms or findings
PET/MRI/Bone Scan	Assesses spread (metastasis) and guides further testing	Staging or when metastasis is suspected
Sputum Cytology	Examines mucus for cancer cells	When a persistent cough is present
Bronchoscopy/Needle Biopsy/Thoracentesis	Obtains tissue or fluid for diagnosis	Follow-up to suspicious imaging

Key Takeaways

Lung cancer screening with LDCT saves lives in high-risk groups and is recommended for certain adults with a significant smoking history.

Multiple types of imaging and tissue sampling may be used to diagnose and stage lung cancer after concerning symptoms or findings.

Emerging blood tests for lung cancer are still in research and not used for routine screening.

Prompt action and open communication with your care team is the best way to ensure effective detection and treatment.

References

Author

medha deb

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb